New research provides hope for childhood cancer sufferers

Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news103812681.html">New research provides hope for childhood cancer sufferers</a></p> <p>Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies.</p>